Varivax vaccine with diluents
Ended Awarded
- Contract number
- SPE2DB25FP9Y8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $59,877
Award facts
- Contract value 100% obligated
- $59,877.15 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $59,877.15 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by September 15, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will fulfill this requirement from its corporate office location. This award represents a single delivery order issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999 and extending through December 2026.
AmerisourceBergen Drug Corp serves as a prime pharmaceutical distributor for federal medical procurement, supplying vaccines, medications, medical devices, and healthcare commodities to support military and veteran healthcare systems. The Varivax delivery order supports the Defense Logistics Agency's medical supply chain operations and aligns with the company's established role as a comprehensive pharmaceutical vendor for the Department of Defense. The underlying IDC vehicle enables AmerisourceBergen Drug Corp to supply a broad range of pharmaceutical products across multiple therapeutic domains to customers including the Defense Health Agency and U.S. Coast Guard. DLA Troop Support has indicated plans to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, demonstrating continued reliance on qualified pharmaceutical distributors to support global military healthcare requirements.
Quick answers
Who was awarded contract SPE2DB25FP9Y8?
SPE2DB25FP9Y8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 22, 2025.
How much is contract SPE2DB25FP9Y8 worth?
The government has obligated $59,877 on SPE2DB25FP9Y8.
Is contract SPE2DB25FP9Y8 an order under another contract?
Yes. SPE2DB25FP9Y8 is a delivery order under SPE2DB20D3103, an indefinite delivery contract.
Was contract SPE2DB25FP9Y8 competed?
The extent of competition for SPE2DB25FP9Y8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award